0001334549-23-000002.txt : 20230111
0001334549-23-000002.hdr.sgml : 20230111
20230111160753
ACCESSION NUMBER: 0001334549-23-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230109
FILED AS OF DATE: 20230111
DATE AS OF CHANGE: 20230111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mazzo David J
CENTRAL INDEX KEY: 0001334549
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33650
FILM NUMBER: 23523671
MAIL ADDRESS:
STREET 1: 110 ALLEN ROAD
STREET 2: 2ND FLOOR
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LISATA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0000320017
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 222343568
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 ALLEN ROAD
STREET 2: SECOND FLOOR
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
BUSINESS PHONE: 908-229-2590
MAIL ADDRESS:
STREET 1: 110 ALLEN ROAD
STREET 2: SECOND FLOOR
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
FORMER COMPANY:
FORMER CONFORMED NAME: CALADRIUS BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20170808
FORMER COMPANY:
FORMER CONFORMED NAME: Caladrius Biosciences, Inc.
DATE OF NAME CHANGE: 20150608
FORMER COMPANY:
FORMER CONFORMED NAME: NeoStem, Inc.
DATE OF NAME CHANGE: 20060906
4
1
wf-form4_167347112819363.xml
FORM 4
X0306
4
2023-01-09
0
0000320017
LISATA THERAPEUTICS, INC.
LSTA
0001334549
Mazzo David J
C/O LISATA THERAPEUTICS, INC.
110 ALLEN ROAD, 2ND FLOOR
BASKING RIDGE
NJ
07920
1
1
0
0
Chief Executive Officer
Common Stock
2023-01-09
4
A
0
60000
0
A
109285
D
Common Stock
2023-01-09
4
F
0
7845
3
D
101440
D
Common Stock
2023-01-10
4
F
0
3470
3.195
D
97970
D
Stock Options (Right to Buy)
3.0
2023-01-09
4
A
0
30000
0
A
2023-01-09
2033-01-09
Common Stock
30000.0
30000
D
Represents 60,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
Includes 69,783 unvested restricted stock.
Shares withheld as payment of a tax liability on vesting of restricted stock.
Includes 63,100 unvested restricted stock.
One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
James Nisco, Attorney-in-Fact for David J. Mazzo
2023-01-11